Related Experiment Video
Updated: Jun 25, 2026
05:21
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Update on universal annual influenza immunization recommendations for children
Anna Bekker1, Courtney Chou, Henry H Bernstein
1Department of Pediatrics, Dartmouth Medical School, General Academic Pediatrics, Children's Hospital at Dartmouth, Lebanon, New Hampshire 03756, USA.
Current Opinion in Pediatrics
|February 27, 2009
Summary
Annual influenza immunization is now recommended for all children aged 6 months to 18 years. Research is ongoing to improve vaccine efficacy and accessibility for universal childhood flu vaccination.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Public Health
Background:
- Current guidelines recommend annual influenza vaccination for all children aged 6 months through 18 years.
- Recent research explores herd immunity, vaccine strain matching, and vaccine efficacy in different formulations.
Purpose of the Study:
- To update on current recommendations for universal annual influenza immunization in children.
- To review recent research findings related to childhood influenza vaccination.
Main Methods:
- Review of current recommendations from the Advisory Committee on Immunization Practices and the American Academy of Pediatrics.
- Synthesis of recent research on influenza vaccine efficacy, safety, and implementation strategies.
Main Results:
- Expanded recommendations for annual influenza vaccination for all children 6 months to 18 years.
- Research highlights include herd immunity effects, vaccine-virus strain matching issues, live attenuated vs. inactivated vaccine efficacy, and infant vaccine tolerance.
- Emphasis on extending vaccination timelines and utilizing alternative sites like schools to improve rates.
Conclusions:
- Annual influenza vaccination recommendations for children have been broadened.
- Ongoing research focuses on optimizing vaccine efficacy, administration, and cost-effectiveness for universal childhood immunization.
Related Concept Videos
01:51Vaccinations
Overview
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...